Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model
| Autor: | Hylander, Bonnie L., Sen, Arindam, Beachy, Sarah H., Pitoniak, Rose, Ullas, Soumya, Gibbs, John F., Qiu, Jingxin, Prey, Joshua D., Fetterly, Gerald J., Repasky, Elizabeth A. |
|---|---|
| Zdroj: | In Journal of Controlled Release 10 November 2015 217:160-169 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect